200 related articles for article (PubMed ID: 26298010)
1. Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.
Hsu CY; Huang PH; Chen TH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
Am J Hypertens; 2016 Apr; 29(4):528-36. PubMed ID: 26298010
[TBL] [Abstract][Full Text] [Related]
2. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
3. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
4. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Oguz Y; Aslan I; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
Clin Transplant; 2009; 23(2):241-8. PubMed ID: 19402217
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
7. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.
Mu J; Feng B; Ye Z; Yuan F; Zeng W; Luo Z; Qi W
J Nephrol; 2011; 24(2):177-84. PubMed ID: 20602330
[TBL] [Abstract][Full Text] [Related]
8. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
Eyileten T; Sonmez A; Saglam M; Cakir E; Caglar K; Oguz Y; Vural A; Yenicesu M; Yilmaz MI
Nephrology (Carlton); 2010 Mar; 15(2):225-9. PubMed ID: 20470283
[TBL] [Abstract][Full Text] [Related]
9. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects.
Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bozentowicz-Wikarek M; Brzozowska A; Mossakowska M; Skalska A; Wiecek A; Chudek J
Clin Chem Lab Med; 2015 Apr; 53(5):793-9. PubMed ID: 25274953
[TBL] [Abstract][Full Text] [Related]
10. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
11. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
[TBL] [Abstract][Full Text] [Related]
12. Assessment of renal dysfunction improves troponin-based short-term prognosis in patients with acute symptomatic pulmonary embolism.
Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Pacho S; Wojciechowski A; Jankowski K; Ciurzyński M; Pruszczyk P
J Thromb Haemost; 2010 Apr; 8(4):651-8. PubMed ID: 20088923
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
Perticone F; Maio R; Perticone M; Sciacqua A; Shehaj E; Naccarato P; Sesti G
Circulation; 2010 Jul; 122(4):379-84. PubMed ID: 20625109
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
[TBL] [Abstract][Full Text] [Related]
15. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
[TBL] [Abstract][Full Text] [Related]
16. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
17. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.
Yokoyama H; Kanno S; Takahashi S; Yamada D; Itoh H; Saito K; Sone H; Haneda M
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1432-40. PubMed ID: 19713288
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
Stefansson VTN; Schei J; Solbu MD; Jenssen TG; Melsom T; Eriksen BO
Kidney Int; 2018 May; 93(5):1183-1190. PubMed ID: 29395334
[TBL] [Abstract][Full Text] [Related]
19. Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study.
Marcos EG; Geelhoed B; Van Der Harst P; Bakker SJL; Gansevoort RT; Hillege HL; Van Gelder IC; Rienstra M
Europace; 2017 Dec; 19(12):1930-1936. PubMed ID: 28108549
[TBL] [Abstract][Full Text] [Related]
20. Interankle systolic blood pressure difference and renal outcomes in patients with chronic kidney disease.
Chen SC; Tsai YC; Huang JC; Lee SC; Chang JM; Hwang SJ; Chen HC
Nephrology (Carlton); 2016 May; 21(5):379-86. PubMed ID: 26370877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
